TD Waterhouse Canada’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,000
Closed -$1.6K 2090
2024
Q3
$1.6K Hold
8,000
﹤0.01% 1655
2024
Q2
$6.32K Hold
8,000
﹤0.01% 1442
2024
Q1
$10.2K Hold
8,000
﹤0.01% 1368
2023
Q4
$9.2K Sell
8,000
-2,000
-20% -$2.67K ﹤0.01% 1272
2023
Q3
$21.2K Hold
10,000
﹤0.01% 1085
2023
Q2
$38.2K Hold
10,000
﹤0.01% 997
2023
Q1
$27K Hold
10,000
﹤0.01% 1044
2022
Q4
$26.2K Hold
10,000
﹤0.01% 1036
2022
Q3
$46.8K Hold
10,000
﹤0.01% 919
2022
Q2
$133K Buy
+10,000
New +$87.3K ﹤0.01% 744

TD Waterhouse Canada's BTCY Position: Q4 2024 in Review

TD Waterhouse Canada sold out of Biotricity, Inc. Common Stock (BTCY) in Q4 2024, closing a stake of 8,000 shares — an estimated $1.6K sold.

TD Waterhouse Canada first reported a position in BTCY in Q2 2022 and held it in 10 quarters. The position peaked at $133K in Q2 2022. 0 funds tracked by Wall St. Rank hold BTCY as of Q4 2024.

  • TD Waterhouse Canada reported no remaining Biotricity, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • TD Waterhouse Canada sold 8,000 Biotricity, Inc. Common Stock shares in Q4 2024, an estimated $1.6K.
  • TD Waterhouse Canada first reported a position in Biotricity, Inc. Common Stock in Q2 2022 and held it in 10 quarters.
  • TD Waterhouse Canada's Biotricity, Inc. Common Stock position peaked at $133K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q4 2024.

Based on TD Waterhouse Canada's 13F filing for Q4 2024, filed 13 Feb 2025.